Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

16 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial.
Svensson B, Boonen A, Albertsson K, van der Heijde D, Keller C, Hafström I. Svensson B, et al. Among authors: albertsson k. Arthritis Rheum. 2005 Nov;52(11):3360-70. doi: 10.1002/art.21298. Arthritis Rheum. 2005. PMID: 16255010 Free article. Clinical Trial.
Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial.
van Vollenhoven RF, Geborek P, Forslind K, Albertsson K, Ernestam S, Petersson IF, Chatzidionysiou K, Bratt J; Swefot study group. van Vollenhoven RF, et al. Among authors: albertsson k. Lancet. 2012 May 5;379(9827):1712-20. doi: 10.1016/S0140-6736(12)60027-0. Epub 2012 Mar 29. Lancet. 2012. PMID: 22464340 Clinical Trial.
Current smoking status is a strong predictor of radiographic progression in early rheumatoid arthritis: results from the SWEFOT trial.
Saevarsdottir S, Rezaei H, Geborek P, Petersson I, Ernestam S, Albertsson K, Forslind K, van Vollenhoven RF; SWEFOT study group. Saevarsdottir S, et al. Among authors: albertsson k. Ann Rheum Dis. 2015 Aug;74(8):1509-14. doi: 10.1136/annrheumdis-2013-204601. Epub 2014 Apr 4. Ann Rheum Dis. 2015. PMID: 24706006 Free PMC article. Clinical Trial.
In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully prevented: data from the methotrexate responders population in the SWEFOT trial.
Rezaei H, Saevarsdottir S, Forslind K, Albertsson K, Wallin H, Bratt J, Ernestam S, Geborek P, Pettersson IF, van Vollenhoven RF. Rezaei H, et al. Among authors: albertsson k. Ann Rheum Dis. 2012 Feb;71(2):186-91. doi: 10.1136/annrheumdis-2011-200038. Epub 2011 Sep 19. Ann Rheum Dis. 2012. PMID: 21930734 Clinical Trial.
The presence of rheumatoid nodules at early rheumatoid arthritis diagnosis is a sign of extra-articular disease and predicts radiographic progression of joint destruction over 5 years.
Nyhäll-Wåhlin BM, Turesson C, Jacobsson LT, Nilsson JÅ, Forslind K, Albertsson K, Rönnelid J, Petersson IF. Nyhäll-Wåhlin BM, et al. Among authors: albertsson k. Scand J Rheumatol. 2011 Mar;40(2):81-7. doi: 10.3109/03009742.2010.509103. Epub 2010 Oct 5. Scand J Rheumatol. 2011. PMID: 20919947
Remission achieved after 2 years treatment with low-dose prednisolone in addition to disease-modifying anti-rheumatic drugs in early rheumatoid arthritis is associated with reduced joint destruction still present after 4 years: an open 2-year continuation study.
Hafström I, Albertsson K, Boonen A, van der Heijde D, Landewé R, Svensson B; BARFOT Study Group. Hafström I, et al. Among authors: albertsson k. Ann Rheum Dis. 2009 Apr;68(4):508-13. doi: 10.1136/ard.2008.087833. Epub 2008 Apr 17. Ann Rheum Dis. 2009. PMID: 18420939
16 results